Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

Delayed Data
As of Dec 06
 +0.18 / +0.08%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 22 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 230.50, with a high estimate of 285.00 and a low estimate of 200.00. The median estimate represents a +3.25% increase from the last price of 223.25.

Analyst Recommendations

The current consensus among 25 polled investment analysts is to Buy stock in Vertex Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jan 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -4.28%
Growthannually 17.81%


Growthquarterly 4.99%
Growthannually 23.42%
Key to the earnings and sales forecast charts.